Cargando…
Prediction of Treatment Outcome with Inflammatory Biomarkers after 2 Months of Therapy in Pulmonary Tuberculosis Patients: Preliminary Results
Pro-inflammatory mediators play an important role in the pathogenesis of pulmonary tuberculosis. Consecutively, 26 pulmonary tuberculosis patients were enrolled in our study based on the exclusion criteria. We have used Spearman’s correlation analysis, hierarchical clustering and regression modellin...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308673/ https://www.ncbi.nlm.nih.gov/pubmed/34206598 http://dx.doi.org/10.3390/pathogens10070789 |
_version_ | 1783728337155260416 |
---|---|
author | Stefanescu, Simona Cocoș, Relu Turcu-Stiolica, Adina Shelby, Elena-Silvia Matei, Marius Subtirelu, Mihaela-Simona Meca, Andreea-Daniela Stanciulescu, Elena Camelia Popescu, Stefana Oana Biciusca, Viorel Pisoschi, Catalina-Gabriela |
author_facet | Stefanescu, Simona Cocoș, Relu Turcu-Stiolica, Adina Shelby, Elena-Silvia Matei, Marius Subtirelu, Mihaela-Simona Meca, Andreea-Daniela Stanciulescu, Elena Camelia Popescu, Stefana Oana Biciusca, Viorel Pisoschi, Catalina-Gabriela |
author_sort | Stefanescu, Simona |
collection | PubMed |
description | Pro-inflammatory mediators play an important role in the pathogenesis of pulmonary tuberculosis. Consecutively, 26 pulmonary tuberculosis patients were enrolled in our study based on the exclusion criteria. We have used Spearman’s correlation analysis, hierarchical clustering and regression modelling to evaluate the association of 11 biomarkers with culture status after antituberculosis treatment. The results of our study demonstrated that six inflammatory biomarkers of 11, C-reactive protein (CRP), white blood cells (WBC), neutrophils, interferon gamma inducible protein 10, C-reactive protein (CRP) to albumin ratio (CAR) and neutrophil to albumin ratio (NAR), were significantly associated with culture negativity. The predictive ability of a composite model of seven biomarkers was superior to that of any single biomarker based on area under the receiver operating characteristic curve (AUC) analysis, indicating an excellent prediction efficacy (AUC:0.892; 95% CI:0.732-1.0). We also found that the highest significant trends and lower levels of CRP and IP-10 were observed in the two-month treated tuberculosis (TB) patients. We believe that our study may be valuable in providing preliminary results for an additional strategy in monitoring and management of the clinical outcome of pulmonary tuberculosis. Using a panel of predictors added a superior value in predicting culture status after anti-TB therapy. |
format | Online Article Text |
id | pubmed-8308673 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83086732021-07-25 Prediction of Treatment Outcome with Inflammatory Biomarkers after 2 Months of Therapy in Pulmonary Tuberculosis Patients: Preliminary Results Stefanescu, Simona Cocoș, Relu Turcu-Stiolica, Adina Shelby, Elena-Silvia Matei, Marius Subtirelu, Mihaela-Simona Meca, Andreea-Daniela Stanciulescu, Elena Camelia Popescu, Stefana Oana Biciusca, Viorel Pisoschi, Catalina-Gabriela Pathogens Article Pro-inflammatory mediators play an important role in the pathogenesis of pulmonary tuberculosis. Consecutively, 26 pulmonary tuberculosis patients were enrolled in our study based on the exclusion criteria. We have used Spearman’s correlation analysis, hierarchical clustering and regression modelling to evaluate the association of 11 biomarkers with culture status after antituberculosis treatment. The results of our study demonstrated that six inflammatory biomarkers of 11, C-reactive protein (CRP), white blood cells (WBC), neutrophils, interferon gamma inducible protein 10, C-reactive protein (CRP) to albumin ratio (CAR) and neutrophil to albumin ratio (NAR), were significantly associated with culture negativity. The predictive ability of a composite model of seven biomarkers was superior to that of any single biomarker based on area under the receiver operating characteristic curve (AUC) analysis, indicating an excellent prediction efficacy (AUC:0.892; 95% CI:0.732-1.0). We also found that the highest significant trends and lower levels of CRP and IP-10 were observed in the two-month treated tuberculosis (TB) patients. We believe that our study may be valuable in providing preliminary results for an additional strategy in monitoring and management of the clinical outcome of pulmonary tuberculosis. Using a panel of predictors added a superior value in predicting culture status after anti-TB therapy. MDPI 2021-06-22 /pmc/articles/PMC8308673/ /pubmed/34206598 http://dx.doi.org/10.3390/pathogens10070789 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Stefanescu, Simona Cocoș, Relu Turcu-Stiolica, Adina Shelby, Elena-Silvia Matei, Marius Subtirelu, Mihaela-Simona Meca, Andreea-Daniela Stanciulescu, Elena Camelia Popescu, Stefana Oana Biciusca, Viorel Pisoschi, Catalina-Gabriela Prediction of Treatment Outcome with Inflammatory Biomarkers after 2 Months of Therapy in Pulmonary Tuberculosis Patients: Preliminary Results |
title | Prediction of Treatment Outcome with Inflammatory Biomarkers after 2 Months of Therapy in Pulmonary Tuberculosis Patients: Preliminary Results |
title_full | Prediction of Treatment Outcome with Inflammatory Biomarkers after 2 Months of Therapy in Pulmonary Tuberculosis Patients: Preliminary Results |
title_fullStr | Prediction of Treatment Outcome with Inflammatory Biomarkers after 2 Months of Therapy in Pulmonary Tuberculosis Patients: Preliminary Results |
title_full_unstemmed | Prediction of Treatment Outcome with Inflammatory Biomarkers after 2 Months of Therapy in Pulmonary Tuberculosis Patients: Preliminary Results |
title_short | Prediction of Treatment Outcome with Inflammatory Biomarkers after 2 Months of Therapy in Pulmonary Tuberculosis Patients: Preliminary Results |
title_sort | prediction of treatment outcome with inflammatory biomarkers after 2 months of therapy in pulmonary tuberculosis patients: preliminary results |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308673/ https://www.ncbi.nlm.nih.gov/pubmed/34206598 http://dx.doi.org/10.3390/pathogens10070789 |
work_keys_str_mv | AT stefanescusimona predictionoftreatmentoutcomewithinflammatorybiomarkersafter2monthsoftherapyinpulmonarytuberculosispatientspreliminaryresults AT cocosrelu predictionoftreatmentoutcomewithinflammatorybiomarkersafter2monthsoftherapyinpulmonarytuberculosispatientspreliminaryresults AT turcustiolicaadina predictionoftreatmentoutcomewithinflammatorybiomarkersafter2monthsoftherapyinpulmonarytuberculosispatientspreliminaryresults AT shelbyelenasilvia predictionoftreatmentoutcomewithinflammatorybiomarkersafter2monthsoftherapyinpulmonarytuberculosispatientspreliminaryresults AT mateimarius predictionoftreatmentoutcomewithinflammatorybiomarkersafter2monthsoftherapyinpulmonarytuberculosispatientspreliminaryresults AT subtirelumihaelasimona predictionoftreatmentoutcomewithinflammatorybiomarkersafter2monthsoftherapyinpulmonarytuberculosispatientspreliminaryresults AT mecaandreeadaniela predictionoftreatmentoutcomewithinflammatorybiomarkersafter2monthsoftherapyinpulmonarytuberculosispatientspreliminaryresults AT stanciulescuelenacamelia predictionoftreatmentoutcomewithinflammatorybiomarkersafter2monthsoftherapyinpulmonarytuberculosispatientspreliminaryresults AT popescustefanaoana predictionoftreatmentoutcomewithinflammatorybiomarkersafter2monthsoftherapyinpulmonarytuberculosispatientspreliminaryresults AT biciuscaviorel predictionoftreatmentoutcomewithinflammatorybiomarkersafter2monthsoftherapyinpulmonarytuberculosispatientspreliminaryresults AT pisoschicatalinagabriela predictionoftreatmentoutcomewithinflammatorybiomarkersafter2monthsoftherapyinpulmonarytuberculosispatientspreliminaryresults |